Curis
CRIS
#10292
Rank
NZ$18.99 M
Marketcap
NZ$1.47
Share price
-1.68%
Change (1 day)
-76.55%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): NZ-$6.38

According to Curis's latest financial reports the company's current EPS (TTM) is NZ-$6.11. In 2024 the company made an earnings per share (EPS) of NZ-$11.70 an increase over its 2023 EPS that were of NZ-$15.03.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.38-45.45%
2024NZ-$11.70-22.15%
2023NZ-$15.03-26.17%
2022NZ-$20.3522.3%
2021NZ-$16.64-25.37%
2020NZ-$22.30-30.93%
2019NZ-$32.29-2.02%
2018NZ-$32.95
2016NZ-$74.89-10%
2015NZ-$83.21138.1%
2014NZ-$34.9540%
2013NZ-$24.96-25%
2012NZ-$33.2866.67%
2011NZ-$19.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$2.86-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.94-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
NZ-$0.60-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$3.96-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$5.62-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ-$18.71 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$2.35-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA